Literature DB >> 7876137

Expression of PG-M(V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment in region in mouse and human tissues.

M Zako1, T Shinomura, M Ujita, K Ito, K Kimata.   

Abstract

We showed previously that the alternative splicing of chondroitin sulfate attachment domains (CS alpha and CS beta) yielded multiforms of the PG-M core protein in mouse. A transcript encoding a new short form of the core protein PG-M(V3) was found in various mouse tissues using polymerase chain reaction. DNA sequences of the polymerase chain reaction products suggested that PG-M(V3) had no chondroitin sulfate attachment domain. PG-M(V3) was also detected in various human tissues. The presence of a transcript for PG-M(V3) was further supported by Northern blot analysis. Southern blot analysis confirmed that multiforms of the PG-M core protein, including PG-M(V3), were derived from a single genomic locus by an alternative splicing mechanism. Because PG-M(V3) has no chondroitin sulfate attachment region, which is the most distinctive portion of a proteoglycan molecule, this form may have a unique function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7876137     DOI: 10.1074/jbc.270.8.3914

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Age-related differences in human skin proteoglycans.

Authors:  David A Carrino; Anthony Calabro; Aniq B Darr; Maria T Dours-Zimmermann; John D Sandy; Dieter R Zimmermann; J Michael Sorrell; Vincent C Hascall; Arnold I Caplan
Journal:  Glycobiology       Date:  2010-10-14       Impact factor: 4.313

2.  Proteolytic cleavage of versican during cardiac cushion morphogenesis.

Authors:  Christine B Kern; Waleed O Twal; Corey H Mjaatvedt; Sarah E Fairey; Bryan P Toole; M Luisa Iruela-Arispe; W Scott Argraves
Journal:  Dev Dyn       Date:  2006-08       Impact factor: 3.780

3.  Versican proteolysis mediates myocardial regression during outflow tract development.

Authors:  Christine B Kern; Russell A Norris; Robert P Thompson; W Scott Argraves; Sarah E Fairey; Leticia Reyes; Stanley Hoffman; Roger R Markwald; Corey H Mjaatvedt
Journal:  Dev Dyn       Date:  2007-03       Impact factor: 3.780

Review 4.  Extracellular matrix of the central nervous system: from neglect to challenge.

Authors:  Dieter R Zimmermann; María T Dours-Zimmermann
Journal:  Histochem Cell Biol       Date:  2008-08-12       Impact factor: 4.304

5.  Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes.

Authors:  Inkyung Kang; Jeremy L Barth; Erin P Sproul; Dong Won Yoon; Gail A Workman; Kathleen R Braun; W Scott Argraves; Thomas N Wight
Journal:  J Biol Chem       Date:  2015-07-07       Impact factor: 5.157

6.  Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease.

Authors:  Loren E Dupuis; Daniel R McCulloch; Jessica D McGarity; Alexandria Bahan; Andy Wessels; Deidra Weber; A Megan Diminich; Courtney M Nelson; Suneel S Apte; Christine B Kern
Journal:  Dev Biol       Date:  2011-07-01       Impact factor: 3.582

Review 7.  The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.

Authors:  Sumeda Nandadasa; Simon Foulcer; Suneel S Apte
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

8.  A Large Chondroitin Sulfate Proteoglycan, Versican, in Porcine Predentin.

Authors:  Saori Okahata; Ryuji Yamamoto; Yasuo Yamakoshi; Makoto Fukae
Journal:  J Oral Biosci       Date:  2011

9.  Correlation of Versican Expression, Accumulation, and Degradation during Embryonic Development by Quantitative Immunohistochemistry.

Authors:  Jessica M Snyder; Ida M Washington; Timothy Birkland; Mary Y Chang; Charles W Frevert
Journal:  J Histochem Cytochem       Date:  2015-09-18       Impact factor: 2.479

10.  Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies.

Authors:  Christine B Kern; Andy Wessels; Jessica McGarity; Laura J Dixon; Ebony Alston; W Scott Argraves; Danielle Geeting; Courtney M Nelson; Donald R Menick; Suneel S Apte
Journal:  Matrix Biol       Date:  2010-01-22       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.